Novel NOTCH2-NTRK1 fusion confers osimertinib resistance in EGFR-mutant non-small cell lung cancer by interacting with EGFR
新型 NOTCH2-NTRK1 融合蛋白通过与 EGFR 相互作用,赋予 EGFR 突变型非小细胞肺癌奥希替尼耐药性。
期刊:Translational Oncology
影响因子:4.5
doi:10.1016/j.tranon.2025.102577.
Hui Li,Huiting Wei,Tiantian Zhen,Huabin Gao,Huicong Liu,Shuai Zheng,Huijuan Shi,Jiangtao Liang,Fenfen Zhang,Jiecheng Ye,Gengpeng Lin,Anjia Han
肺癌
细胞生物学
肿瘤
EGF
EGFR
NOTCH
NTRK1
OTC
Trk
Notch